We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00159250
Recruitment Status : Completed
First Posted : September 12, 2005
Last Update Posted : February 23, 2010
Department of Health, United Kingdom
Information provided by:
Imperial College London